Nasdaq ctso.
Apr 13, 2021 · A look at the shareholders of Cytosorbents Corporation (NASDAQ:CTSO) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership.
If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...02 Jun, 2022, 07:00 ET. PRINCETON, N.J., June 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit ...According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings expectations. Reported EPS is $-0.20718 EPS, expectations were ...
Find the latest SEC Filings data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com.
Cytosorbents Co. (NASDAQ:CTSO) announced its quarterly earnings data on Thursday, November, 4th. The medical research company reported ($0.15) earnings …About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...
On Invalid Date, . Cytosorbents (NASDAQ: CTSO) reported Q3 2023 earnings per share (EPS) of -$0.21, up 25% year over year. Total Cytosorbents earnings for the quarter were -$9.19 million.In the same quarter last year, Cytosorbents's earnings per share (EPS) was …Hisse senedi fiyat hareketlerini izlemek için canlı Cytosorbents Corporation grafiğini görüntüleyin. Piyasa tahminlerini, CTSO finansalları ve piyasa haberlerini bulun.CTSO - Cytosorbents Corp Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Market Activity. Funds + ETFs. Indexes. Currencies. Real-Time Quotes. After-Hours Quotes. Pre-Market Quotes. Nasdaq-100. News + Insights.
As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.
Jan 31, 2023 · CTSO CytoSorbents Corporation CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue PR Newswire PRINCETON, N.J., Jan. 31, 2023 Cumulative CytoSorb treatments surpassed 195,000....
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi... Menu icon A vertical stack of three evenly ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...According to the issued ratings of 2 analysts in the last year, the consensus rating for Cytosorbents stock is Buy based on the current 2 buy ratings for CTSO. The average twelve-month price prediction for Cytosorbents is $4.75 with a high price target of $5.50 and a low price target of $4.00. Learn more on CTSO's analyst rating history.About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...CTSO Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 08:27:28. $1.47. 6.CTSO CytoSorbents Corporation Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 ...
Mar 9, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... CTSO CTSO AFTER HOURS QUOTE CTSO LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ... According to 2 analysts, the average rating for CTSO stock is "Strong Buy." The 12-month stock price forecast is $4.75, which is an increase of 278.49% from the latest price.PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using ...Find the latest SEC Filings data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com.The latest price target for CytoSorbents ( NASDAQ: CTSO) was reported by B. Riley Securities on Thursday, September 7, 2023. The analyst firm set a price target for 4.00 expecting CTSO to rise to ...
Nov 17, 2023 · CTSO CytoSorbents Corporation Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 ... PRINCETON, N.J., Dec. 29, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...
Sep 19, 2022 · So spare a thought for the long term shareholders of Cytosorbents Corporation (NASDAQ:CTSO); the share price is down a whopping 78% in the last twelve months. While some investors are willing to ... MONMOUTH JUNCTION, N.J., (PRNewswire) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...8 Nov 2023 ... Cytosorbents (NASDAQ:CTSO) is scheduled to announce Q3 earnings results on Thursday, November 9th, after market close.02 Jun, 2022, 07:00 ET. PRINCETON, N.J., June 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...
NASDAQ:CTSO. READ THE FULL CTSO RESEARCH REPORT. CytoSorbents (NASDAQ:CTSO) reported 1st quarter 2023 results on March 2nd with revenue results largely in line with expectations. 1st quarter revenues increased 8.7% to $9.4 million from $8.7 million in the prior year period. Product sales were essentially flat …
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. About the company. CTSO fundamental analysis. Snowflake Score.
CTSO After-Hours Quotes. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of ...Jul 11, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... MONMOUTH JUNCTION, N.J., July 31, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that the ...Nov 24, 2023 · CTSO CytoSorbents Corporation Form 8-K - Current report 0001175151 false 0001175151 2023-09-27 2023-09-27 iso4217:USD xbrli:shares ... Shares of CytoSorbents ( CTSO 4.27%) were getting clobbered on Tuesday, with the stock sinking 15.9% as of 3:14 p.m. EDT. The big decline came after the maker of blood purification technologies ...By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT CytoSorbents (NASDAQ:CTSO) reported 3rd quarter 2023 results on November 9th which showed strong product revenue growth. 3rd quarter product revenues increased 20% to $7.8 million and grant income decreased 35.9%. The increase in the Euro to U.S. dollar …21 Sep 2023 ... Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference ; CytoSorbents Corporation, NASDAQ: CTSO, https:// ...Pre-Market Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ... The public float for CTSO is 38.46M, and currently, short sellers hold a 4.23% ratio of that floaft. The average trading volume of CTSO on November 21, 2023 was 82.33K shares. CTSO) stock’s latest price update. Cytosorbents Corp (NASDAQ: CTSO)’s stock price has soared by 22.81 in relation to previous closing price of 1.14.
CTSO NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials . Technicals . Forecast . CTSO technical analysis. This gauge …About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...Sep 1, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... CytoSorbents (NASDAQ:CTSO) Historical Stock Chart From Oct 2023 to Nov 2023 CytoSorbents (NASDAQ:CTSO) Historical Stock Chart From Nov 2022 to Nov 2023 Latest CTSO MessagesInstagram:https://instagram. li cycle stock pricedoes state farm offer business insuranceguardian vision 180ares capital corporation stock CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue PR Newswire PRINCETON, N.J., Jan. 31, 2023 Cumulative CytoSorb treatments surpassed 195,000.... orcl tickernuscale power corp Cytosorbents (NASDAQ:CTSO) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway Jan 10. Health Canada Authorizes CytoSorb for Use in Hospitalized Covid-19 Patients Jan 05. CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing elon musk fasting app צפה בגרף Cytosorbents Corporation בזמן אמת כדי לעקוב אחר תנועת מחיר המניה. תמצא תחזיות שוק, CTSO וחדשות שוק כלכליות.PRINCETON, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...Jun 2, 2022 · 02 Jun, 2022, 07:00 ET. PRINCETON, N.J., June 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit ...